NasdaqGS - Nasdaq Real Time Price
USD
Gossamer Bio, Inc. (GOSS)
10.38
-0.31
(-2.90%)
At close: October 30 at 4:00:01 PM EDT
10.15
-0.23
(-2.22%)
Pre-Market: 3:13:25 AM EST
Analyst Insights
Top Analyst
Wedbush
60/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/26/2026
Analyst
Chardan Capital
Rating Action
Maintains
Rating
Buy
Price Action
Maintains
Price Target
160 -> 160
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Wedbush
|
60 | 40 | 81 | Neutral
|
80 | 2026-02-25 |
|
HC Wainwright & Co.
|
57 | 42 | 79 | Buy
|
90 | 2026-09-22 |
|
Barclays
|
51 | 29 | 81 | Underweight
|
22.4 | 2026-05-20 |
|
Cantor Fitzgerald
|
26 | 12 | 40 | Neutral
|
- | 2026-03-24 |
Rows per page
1-4 of 4
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 10/26/2026 |
| Maintains | Chardan Capital: Buy to Buy | 10/15/2026 |
| Initiated | Chardan Capital: Buy | 10/13/2026 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 9/21/2026 |
| Maintains | Piper Sandler: Overweight to Overweight | 8/14/2026 |
| Upgrade | Leerink Partners: Market Perform to Outperform | 7/28/2026 |
